Company
Headquarters: New York, NY, United States
Employees: 284
CEO: Mr. Daniel S. McKinney
$40.6 Million
USD as of Jan. 1, 2024
Company | Market Cap (USD) |
---|---|
CRH plc | $46.37 B |
Martin Marietta Materials, Inc. | $30.04 B |
Vulcan Materials Company | $29.32 B |
Heidelberg Materials AG | $16.43 B |
James Hardie Industries plc | $16.29 B |
Company | Market Cap (USD) |
---|---|
Linde | $198.22 B |
BHP | $169.91 B |
Rio Tinto | $120.67 B |
Air Liquide SA | $101.75 B |
Shin-Etsu Chemical Co Ltd | $82.56 B |
EV Biologics, Inc., a biotechnology company, engages in the commercial development of extracellular vesicles (EVs) as biological modalities for diagnostics and therapeutics. It is involved in developing vaccines, therapeutics, and cures based on its proprietary multifunctional EV platform. The company also focuses on developing human mesenchymal and other stem cell, and cell-derived products to market in the cosmetic and biopharmaceutical spaces. The company was formerly known as Yulong Eco-Materials Limited and changed its name to EV Biologics, Inc. in August 2020. EV Biologics, Inc. was incorporated in 2011 and is headquartered in Cheyenne, Wyoming.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Yulong Eco-Materials Ltd has the following listings and related stock indices.
Stock: OTC: YECO wb_incandescent